Acquired Immunodeficiency Syndrome  >>  sofosbuvir/velpatasvir  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
sofosbuvir/velpatasvir / Generic mfg.
NCT02480712: Efficacy and Safety of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection

Completed
3
107
US
SOF/VEL, GS-7977/GS-5816, Epclusa®
Gilead Sciences
Hepatitis C Virus Infection
04/16
06/16

Download Options